🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study，lenalidomide was added in the first-line treatment in the new...
Status
Unknown
Location
Department of Hematology, Provincial Hospital Affiliated to Shandong University
Start Date
2019-06-05
Trial ID
NCT04152577
Treatments Being Tested
The overarching hypothesis for this study is that a safe and tolerable dose...
Status
Active Not Recruiting
Location
University of Texas Southwestern
Start Date
2023-01-26
Trial ID
NCT05270057
The prognosis of patients with "high-grade B cell lymphoma with cellular my...
Status
Active Not Recruiting
Location
BE-Antwerpen-ZNASTUIVENBERG
Start Date
2018-08-01
Trial ID
NCT03620578
Treatments Being Tested
The prognosis of DLBCL with MYC rearrangement is dismal. Previous study sho...
Status
Recruiting
Location
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital)
Start Date
2020-06-09
Trial ID
NCT04432714
Treatments Being Tested
The subject is invited to take part in this research study because s/he has...
Status
Completed
Location
Texas Children's Hospital
Start Date
2013-01
Trial ID
NCT01760226
This research study is evaluating the combination of a study drug, venetocl...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2017-03-08
Trial ID
NCT03054896
Treatments Being Tested
This phase II trial studies how well epcoritamab works in combination with ...
Status
Not Yet Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2026-09-17
Trial ID
NCT07662928
The aim of this study is to evaluate the efficacy and toxicity of dose-adju...
Status
Terminated
Location
Fudan University Cancer Hospital
Start Date
2013-02
Trial ID
NCT01914718
Treatments Being Tested
This randomized phase II trial is studying two different combination chemot...
Status
Unknown
Location
Oncology center
Start Date
2016-06-01
Trial ID
NCT03188198
Treatments Being Tested
This compares the effects of nivolumab at a fixed dose of 40 mg with chemo-...
Status
Recruiting
Location
National Research Center for Hematology
Start Date
2022-04-01
Trial ID
NCT06188676